These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9795769)

  • 21. Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation.
    Murray JS; Oney S; Page JE; Kratochvil-Stava A; Hu Y; Makagiansar IT; Brown JC; Kobayashi N; Siahaan TJ
    Chem Biol Drug Des; 2007 Sep; 70(3):227-36. PubMed ID: 17718717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
    Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS
    Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope.
    Jaume JC; Parry SL; Madec AM; Sønderstrup G; Baekkeskov S
    J Immunol; 2002 Jul; 169(2):665-72. PubMed ID: 12097368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
    Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
    J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of GAD65 peptides and I-Ag7 in the development of insulitis in nonobese diabetic mice.
    Ogino T; Sato K; Miyokawa N; Kimura S; Katagiri M
    Immunogenetics; 2000 Jun; 51(7):538-45. PubMed ID: 10912505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes.
    Lohmann T; Leslie RD; Londei M
    J Autoimmun; 1996 Jun; 9(3):385-9. PubMed ID: 8816975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.
    Olcott AP; Tian J; Walker V; Dang H; Middleton B; Adorini L; Washburn L; Kaufman DL
    J Immunol; 2005 Aug; 175(3):1991-9. PubMed ID: 16034144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
    Sévère S; Gauvrit A; Vu AT; Bach JM
    Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.
    Serreze DV; Fleming SA; Chapman HD; Richard SD; Leiter EH; Tisch RM
    J Immunol; 1998 Oct; 161(8):3912-8. PubMed ID: 9780157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
    Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
    Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.
    Geng L; Solimena M; Flavell RA; Sherwin RS; Hayday AC
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10055-60. PubMed ID: 9707599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
    Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
    J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
    Gerling IC; Atkinson MA; Leiter EH
    J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
    J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation and maintenance of autoantigen-specific CD8(+) T cell clones isolated from NOD mice.
    Bowie L; Tite J; Cooke A
    J Immunol Methods; 1999 Aug; 228(1-2):87-95. PubMed ID: 10556546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.
    Chao CC; Sytwu HK; Chen EL; Toma J; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9299-304. PubMed ID: 10430937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
    Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
    Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.